Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

P-TEFb inhibitor

DRUG CLASS:

P-TEFb inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

BAY 1143572 (0)

BAY 1143572 (0)

›

MYCN amplification	Rhabdomyosarcoma	MYCN amplification	Rhabdomyosarcoma	selinexor + VIP152 Sensitive: D – Preclinical selinexor + VIP152 Sensitive : D	selinexor + VIP152 Sensitive: D – Preclinical selinexor + VIP152 Sensitive : D
MYCN amplification	Rhabdomyosarcoma	MYCN amplification	Rhabdomyosarcoma	bortezomib + VIP152 Sensitive: D – Preclinical bortezomib + VIP152 Sensitive : D	bortezomib + VIP152 Sensitive: D – Preclinical bortezomib + VIP152 Sensitive : D
MYCN amplification	Rhabdomyosarcoma	MYCN amplification	Rhabdomyosarcoma	VIP152 Sensitive: D – Preclinical VIP152 Sensitive : D	VIP152 Sensitive: D – Preclinical VIP152 Sensitive : D
MYCN amplification	Neuroblastoma	MYCN amplification	Neuroblastoma	VIP152 Sensitive: D – Preclinical VIP152 Sensitive : D	VIP152 Sensitive: D – Preclinical VIP152 Sensitive : D
MYCN amplification	Rhabdomyosarcoma	MYCN amplification	Rhabdomyosarcoma	carfilzomib + VIP152 Sensitive: D – Preclinical carfilzomib + VIP152 Sensitive : D	carfilzomib + VIP152 Sensitive: D – Preclinical carfilzomib + VIP152 Sensitive : D